Literature DB >> 7781810

Medullary cell carcinoma of the thyroid: metastases to the central nervous system.

J Timothy1, C Kerawala, L Brazil, J Bartlett, B Doshi.   

Abstract

We document a case of a patient who had been treated for a medullary cell carcinoma of the thyroid three years previously and who presented with a three month history of ataxia, weakness and headache. A CT scan showed contrast enhancing lesions in the posterior fossa. An MIBG uptake scan showed that there was some uptake in the cerebellar lesions; however, it was not sufficient to rely on this alone for treatment. The larger of these lesions was therefore surgically resected. Immunocytochemistry, using CAM 5.2, CEA and chromogranin, demonstrated a positive reaction which strongly favoured a diagnosis of metastases from a medullary cell carcinoma of the thyroid. However, absolute confirmation of the diagnosis was obtained using immunocytochemistry with calcitonin. Medullary cell carcinomas of the thyroid usually spread locally and metastasis to the brain has never before been reported.

Entities:  

Mesh:

Year:  1995        PMID: 7781810     DOI: 10.1016/s0748-7983(95)91987-2

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

1.  Brain metastasis from medullary thyroid carcinoma.

Authors:  P Börcek; S L Asa; F Gentili; S Ezzat; T-R Kiehl
Journal:  BMJ Case Rep       Date:  2010-12-29

2.  Giant intracranial medullary thyroid carcinoma metastasis presenting as apoplexy.

Authors:  Matthew Bobinski; Claudia M Greco; Rudolph J Schrot
Journal:  Skull Base       Date:  2009-09

Review 3.  Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature.

Authors:  M Salvati; A Frati; G Rocchi; R Masciangelo; A Antonaci; F M Gagliardi; R Delfini
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

4.  Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer.

Authors:  Joana Simões-Pereira; Daniel Macedo; Maria João Bugalho
Journal:  Endocr Connect       Date:  2016-11-17       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.